FLI Seminar with Corinne Benakis: Microbial metabolites as immunomodulators in stroke

Seminars Science

Neuroscientist Corinne Benakis (PhD) from the Institute for Stroke and Dementia Research (ISD) at the University Hospital of Ludwig-Maximilians-University Munich, will speak on September 4th at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) about current findings on the molecular pathomechanisms of the gut-brain axis.

The gut microbiota has emerged as a dynamic player, not only in gastrointestinal diseases, but also in its profound influence on distant organs, particularly the brain.

Gut bacteria are considered a potential regulatory mechanism for the transport of immune cells from the gut to the brain. There is a direct correlation with the severity of a stroke. However, the microbial cues modulating immune cells polarization and mobilization remain elusive.

In her presentation, Corinne Benakis (PhD) will discuss the latest findings on the molecular pathomechanisms of the gut-brain axis. The Junior group leader of the Microbiome–gut–brain axis Lab will focus on metabolites produced

Information about Corinne Benakis (PhD):
-   Institute for Stroke and Dementia Research (ISD) at the University Hospital of the Ludwig-Maximilians-University (LMU) Munich
 

Title of Talk:Microbial metabolites as immunomodulators in stroke
When:Wednesday, September 04, 2024, 3:00 p.m.
Where:Seminar room “Nucleus”, main building (FLI 1), Beutenbergstraße 11, Jena
Host:       Katarzyna Winek (Junior group leader Microbiome in Stroke and Aging)

The seminar will be a hybrid event. Details for accessing the session will be provided before the colloquium takes place. For external guests: Please contact Nicole.Wolf@leibniz-fli.de for details.